COMPLIMENTARY DOWNLOAD

The Altascientist: The Advantages of Conducting 

Early Phase Clinical Research in Canada

 

The Altascientist issue 27 - The Complexities of Early Phase Ophthalmic Drug Development How an end-to-end solution can facilitate a path to Phase IIIn this scientific publication, learn about the significant advantages of conducting early phase clinical research on novel compounds in Canada versus other locations.

We discuss:

  • Canadian CTA Trials – Time and Cost Savings
  • Regulatory Review Process Predictability
  • Business Efficiency Cost Savings
  • Clinical Trial Participants
  • Canadian CTA Frequently Asked Questions

COMPLETE THE FORM TO DOWNLOAD